A white circular icon with lines and nodes representing a network

Global Substance Registration System

Project Charter

The goal of the system is to make it easier for regulators and other stakeholders to exchange information about substances in medicines, supporting scientific research on the use and safety of the ingredients in medicinal products.

The Challenge

The GSRS is a registration system for the ingredients in medicinal products. The creation of the GSRS was a collaborative effort between the FDA, NIH and EMA, and driven by the need to accurately track the global supply chain of ingredients in regulated products.

In practice, the system serves a multiplicity of use cases beyond providing a standard substance registry, and there is limited stakeholder governance to guide ongoing and future system development, and to provide financial stability.

What does the project aim to achieve?

In order to address the current challenges with the GSRS system, and to build a vision for the future that could include the harmonisation of regulatory systems, the proposal is to create a consortium of GSRS stakeholders led by the Pistoia Alliance.

The proposed Consortia would form the governing body for the GSRS. The mission of the Consortia would be to develop a shared vision for GSRS, develop and enact a business plan to attain the vision, and guide ongoing development and maintenance of the system.

The consortia should, at a minimum, include stakeholders from:

  • Pharmaceutical companies
  • Health Authorities including, but ideally not limited to the FDA and EMA
  • NIH/NCATS
  • US Pharmacopeia

The multi-year vision, strategy and business plan should include the:

  • As is state of the GSRS and the vision for the future
  • Viable governance framework
  • Business model with a sustainable funding mechanism
  • Architectural analysis
  • Process for release management including testing, documentation, release schedules, implementation and support guides
  • Support models
  • Alignment on standards, terminologies and minimum metadata requirements.

We propose initiating a multi-stakeholder project to define the multi-year strategy, vision and governance framework, and to determine if there is a viable business model to sustain the Consortia.

The resulting deliverables will include:

  • Development of a business case that meets the needs of all primary stakeholders with a viable funding model for development and maintenance of the system
  • Agreement on a governance approach that balances immediate and long-term needs and delivers value to all stakeholders
  • A governance, development model and system architecture that works with in today’s fast changing business, regulatory and technology environments

Get Involved

Talk to to our project manager, to learn more

Contact Birthe Nielsen

Project Partners

  • GSK logo

Our Events

11 Jun 2026

How AI is Redefining User Experience in Life Sciences

Book Now
16 Jun 2026

Japan Roundtable Discussion: AI and AI agents in ELN and LIMS workflows

Book Now
17 Jun 2026

From Data Access to Data Readiness

Book Now
18 Jun 2026

Common Challenges in Chemical Exchange Formats

Book Now
23 Jun 2026

European Life Science Informatics Forum – Nordics Chapter #2

Book Now
24 Jun 2026

Life Science AI Exchange: Agentic AI and Technology Best Practices

Book Now
24 Jun 2026

US Life Science Informatics Forum

Book Now
25 Jun 2026

Partner Event: Rev London

Book Now
16 Jul 2026

Joint Meeting of the Pistoia Alliance / EMBL-EBI / ELIXIR

Book Now
22 Jul 2026

Life Science AI Exchange: Rolling to Production — Change Management, Adoption & Maintenance

Book Now
19 Aug 2026

Life Science AI Exchange Round Table: Regulatory Readiness — GxP Compliance & Validation Requirements

Book Now
22 Sep 2026

Partner Event: Lab of the Future Congress

Book Now
29 Sep 2026

2026 CSCS Conference

Book Now
20 Oct 2026

2026 User Experience in Life Sciences (UXLS) Conference

Book Now
10 Nov 2026

Boston 2026 Conference

Book Now
16 Nov 2026

Quantum Computing in Pharma R&D: Where are we?

Book Now